American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions.The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
Who Is on the Research Team?
Robert Martin, MD, PhD
Principal Investigator
University of Louisville
Are You a Good Fit for This Trial?
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo pancreatic irreversible electroporation (IRE) treatment for unresectable soft tissue pancreatic tumors
Follow-up
Participants are monitored for safety, effectiveness, and adverse events after treatment
Long-term follow-up
Capture overall survival and long-term adverse events in patients treated with IRE
What Are the Treatments Tested in This Trial?
Interventions
- Pancreatic Irreversible Electroporation (IRE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
The Americas Hepato-Pancreato-Biliary Association
Collaborator